We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · March 13, 2021

Utility of the MARS-5 in Assessing Medication Adherence in Inflammatory Bowel Disease

Inflammatory Bowel Diseases


Additional Info

Disclosure statements are available on the authors' profiles:

Inflammatory Bowel Diseases
Utility of the MARS-5 in Assessing Medication Adherence in IBD
Inflamm. Bowel Dis. 2021 Mar 01;27(3)317-324, JK Stone, LA Shafer, LA Graff, L Lix, K Witges, LE Targownik, C Haviva, K Sexton, CN Bernstein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading